10-K: Pennant Group Reports Strong 2025 Growth, Expands Footprint

The Pennant Group, Inc. announced significant revenue and net income growth in 2025, driven by robust organic expansion and strategic acquisitions across its home health, hospice, and senior living segments.

Summary

• Total revenue increased by 36.3% to $947.7 million for the year ended December 31, 2025, compared to $695.2 million in 2024.
• Net income attributable to The Pennant Group, Inc. rose by 31.1% to $29.6 million in 2025, up from $22.6 million in 2024.
• Consolidated Adjusted EBITDA grew by 36.0% to $72.5 million in 2025, compared to $53.3 million in 2024.
• The company expanded its operations with the acquisition of 30 home health agencies, 9 hospice agencies, 4 home care agencies, and 6 senior living communities in 2025.
• A major acquisition in Q4 2025 included 21 home health, 5 hospice, and 4 home care agencies in Alabama, Georgia, and Tennessee from UnitedHealth Group Incorporated and Amedisys, Inc., including a 67% ownership in a joint venture.
• Organic revenue growth from existing operations contributed $67.5 million, or 9.7%, to the total revenue increase in 2025.
• Home health and hospice services revenue increased by 41.0% to $732.7 million, with total home health admissions up 44.1% and average hospice daily census up 28.6%.
• Senior living services revenue increased by 22.3% to $215.0 million, driven by an 8.0% increase in average monthly revenue per occupied unit and a 90 basis point increase in occupancy to 79.7%.
• The company's home health agencies achieved an average of 4.2 out of 5 stars in CMS quality ratings for 2025, significantly above the industry average of 3.0 stars.
• As of December 31, 2025, the company operated 172 home health and hospice agencies and 63 senior living communities with 4,428 units across 16 states.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a strong performance driven by robust organic growth and strategic acquisitions, significantly expanding its footprint and improving key financial metrics while maintaining high quality of care ratings. The company is well-positioned to capitalize on favorable industry trends.

Positives

• Total revenue increased by 36.3% year-over-year, demonstrating strong top-line growth.
• Net income attributable to Pennant Group increased by 31.1% year-over-year, indicating improved profitability.
• Consolidated Adjusted EBITDA grew by 36.0% year-over-year, reflecting strong operational performance.
• The company achieved significant organic growth of 9.7% across all segments, complementing its acquisition strategy.
• Strategic acquisitions, including the largest to date from UnitedHealth and Amedisys, expanded the company's footprint into new states and diversified its service offerings.
• Home health agencies maintained a superior CMS quality rating of 4.2 stars, well above the industry average of 3.0 stars, enhancing reputation and referral potential.
• Senior living occupancy improved by 90 basis points to 79.7%, alongside an 8.0% increase in average monthly revenue per occupied unit.
• The company maintains a diversified payor mix (48.4% Medicare, 13.1% Medicaid, 15.0% managed care, 23.5% private pay), providing business stability.

Negatives

• Cost of services as a percentage of revenue increased by 80 basis points to 81.1% in 2025, primarily due to increased wages and benefits.
• Senior living cost of services as a percentage of revenue increased by 150 basis points to 72.6% due to higher occupancy, acquisitions, and wage rate increases.
• The net payment update percentage for the CY 2026 Home Health Prospective Payment System (HH Payment Final Rule) is -1.3%, resulting in an estimated aggregate decrease of $220 million in payments across all home health providers.
• The effective tax rate increased to 26.0% in 2025 from 22.4% in 2024, primarily due to changes in discrete tax effects of share-based compensation.
• Net cash used in investing activities increased significantly by $157.3 million, primarily driven by a $154.7 million increase in business and asset acquisitions.

Risks

• Revenue could be adversely impacted by federal changes to Medicare reimbursement rates, caps, deductibles, and rules, which are subject to frequent and unpredictable changes.
• Reductions in Medicaid reimbursement rates or changes in the rules governing the Medicaid program, including impacts from the One Big Beautiful Bill Act (OBBBA) of 2025, could materially and adversely affect revenues and profitability.
• Ongoing U.S. healthcare system reforms, including proposals for Medicare-for-All or public option insurers, could lower reimbursement or increase the cost of doing business.
• The company is subject to various government reviews, audits, and investigations, which could result in obligations to refund payments, fines, penalties, payment suspensions, or loss of participation in Medicare and Medicaid programs.
• Failure to comply with extensive and complex federal, state, and local laws and regulations could lead to civil or criminal penalties, denial of reimbursement, and loss of licenses.
• Future cost containment initiatives by third-party payors, including managed care organizations, may limit future revenue and profitability by lowering payment rates or narrowing network providers.
• Adverse economic developments, including continued deficit spending or state budget pressures, could lead to reductions or delays in government-funded program payments, impacting liquidity.
• Increased competition for, or a shortage of, nurses and other skilled personnel could increase staffing and labor costs and negatively impact operations.
• The loss of key executive management or local leaders could harm the business due to the highly competitive market for qualified individuals.
• Hospice independent operating subsidiaries are subject to annual Medicare caps, and exceeding these caps requires reimbursement to Medicare, potentially leading to losses if caps do not keep pace with operating costs.
• Security breaches and other cyber-security incidents pose a material risk, potentially leading to theft of confidential information, service disruptions, negative publicity, and substantial regulatory or civil penalties.
• State efforts to regulate or deregulate the healthcare services industry, including certificate of need (CON) requirements or moratoriums on new licenses (e.g., California's hospice licensing moratorium until January 1, 2027), could impair expansion or increase competition.
• Changes in federal and state employment-related laws and regulations, including wage and hour claims, could increase the cost of doing business.
• Delays in receiving required regulatory approvals for acquisitions or transfers of healthcare operations could result in delayed or lost reimbursement.
• The company is subject to litigation, including professional liability claims, elder abuse, wrongful death, and False Claims Act lawsuits, which could result in significant legal costs and large settlement amounts or damage awards.
• The inability to complete future acquisitions at attractive prices or to successfully integrate acquired operations could adversely affect revenue growth and profitability.
• Failure to achieve and maintain competitive quality of care ratings from CMS and private organizations could negatively affect referral volumes and business.
• Difficulty in obtaining or increased costs of insurance coverage, including general and professional liability, workers' compensation, and property and casualty insurance, could adversely affect the business.
• The potential for unionization of workers could increase operating costs and disrupt operations.
• Risks associated with leased properties, including triple-net lease obligations and potential defaults under master lease arrangements, could adversely affect financial position.
• A downturn in housing markets could decrease demand for assisted living services, impacting occupancy rates and revenues.
• Failure to generate sufficient cash flow to cover required payments under long-term debt and operating leases could result in defaults and cross-defaults.
• Inflation may negatively impact profitability by increasing wages, supplies, energy costs, and interest rates, potentially outpacing reimbursement rate adjustments.
• Changes to immigration law or enforcement could reduce the eligible labor pool and increase wage costs.
• Extreme weather, natural disasters, or other catastrophic events could disrupt services, cause damages not covered by insurance, and increase costs.
• Delays in reimbursement from state programs or procedural issues could cause liquidity problems.
• Compliance with Department of Housing and Urban Development (HUD) regulations for certain senior living communities may require unanticipated expenditures or lead to operational limitations.
• As a holding company, The Pennant Group, Inc. relies on distributions from its independent operating subsidiaries to meet financial obligations, which are subject to various restrictions.
• Potential conflicts of interest exist due to two directors serving on both Pennant and Ensign Group boards and executive officers/directors owning Ensign common stock.

Future Outlook

The company anticipates continued organic growth within its existing and newly acquired portfolios by improving clinical outcomes and operational results. It plans to pursue a disciplined acquisition strategy in the fragmented home health, hospice, and senior living industries and leverage operational capabilities to expand partnerships, including potential additional joint ventures. The company expects to benefit from favorable demographic shifts and industry trends rewarding quality care in lower-cost settings, despite ongoing cost containment pressures and regulatory changes in the healthcare sector.

Management Comments

• We believe that, through our innovative operating model, we can foster a new level of patient care and professional competence at our independent operating subsidiaries and set new industry standards for quality home health and hospice and senior living services.
• Our local teams are motivated and empowered to quickly and proactively meet the needs of those they serve, without waiting for permission to act or being bound to a one-size-fits-all corporate strategy.
• We view ourselves as a leadership company, with our growth strategy focused on expanding our talent base and recruiting and developing future leaders.

Industry Context

StockSavvy.ai notes that The Pennant Group operates within a robust and growing U.S. healthcare sector, projected to reach 20.3% of GDP by 2033. The home health and hospice markets are expected to grow at compounded annual growth rates (CAGR) of 8.0% and 8.1% respectively from 2024 to 2030, while the senior living market is projected to grow at a 4.2% CAGR. The company's significant revenue growth of 36.3% in 2025, far exceeding these industry averages, suggests strong market share gains and successful execution of its acquisition strategy in highly fragmented markets. The company's focus on lower-cost settings and value-based payment models aligns well with broader industry trends driven by an aging population and cost containment pressures.

Comparison to Industry Standards

• The company's home health agencies achieved an average of 4.2 out of 5 stars in CMS quality ratings for 2025, significantly outperforming the industry average of 3.0 stars, indicating superior patient care outcomes compared to competitors.
• The company's total revenue growth of 36.3% in 2025 substantially exceeds the projected compounded annual growth rates for the home health market (8.0%), hospice market (8.1%), and senior living market (4.2%) from 2024 to 2030, suggesting strong competitive performance and successful market penetration.
• The company's strategy of acquiring strategic and underperforming operations in highly fragmented markets (where the top ten largest home health operators account for ~25% and hospice ~20%, and top 25 senior living operators own ~28% of licensed beds) positions it to continue consolidating market share more effectively than smaller, regional providers.

Legal Proceedings

• The company is involved in various claims and lawsuits arising in the ordinary course of business, none of which are expected to have a material adverse effect on results of operations or financial condition.
• Subject to potential lawsuits under the False Claims Act (FCA) and comparable state laws alleging submission of fraudulent claims for services to healthcare programs.
• As of December 31, 2025, 12 independent operating subsidiaries had Medicare probe reviews (UPIC, RAC, ZPIC, PSC, SMRC, MIC programs) scheduled, on appeal, or in dispute resolution process.

Related Party Transactions

• Incurred costs of $589,000 in 2025 related to shared services with The Ensign Group, Inc. (Ensign).
• Expenses for room and board charges at Ensign skilled nursing facilities for hospice patients totaled $7,150,000 in 2025.
• Leased 32 senior living communities from subsidiaries of Ensign under master lease arrangements as of December 31, 2025.
• Two directors serve on both Pennant and Ensign boards, and executive officers/directors own Ensign common stock, creating potential conflicts of interest.

Stakeholder Impact

• **Shareholders**: Positive impact from strong revenue and net income growth, successful acquisitions, and high quality ratings. Potential for dilution from equity raises.
• **Employees**: Continued focus on attracting, developing, and retaining talent through training programs and a supportive work environment. However, industry-wide shortages and wage inflation pose ongoing challenges.
• **Patients/Residents**: Benefit from the company's commitment to high-quality care, evidenced by superior CMS star ratings and a patient-centered approach leading to improved clinical outcomes.
• **Payors**: Positioned as a partner of choice due to the delivery of quality outcomes in lower-cost settings, aligning with the industry's shift towards value-based payment models.
• **Referral Sources**: Strong relationships and a reputation for superior care are expected to encourage continued and increased referrals.
• **Creditors**: The company's compliance with financial covenants under its credit agreements provides stability, but significant debt and lease obligations require careful management of cash flow.

Next Steps

• Continue to expand the talent base and develop future leaders through rigorous CEO-in-Training and Clinical Operations Leadership Training programs.
• Focus on driving organic growth within existing and newly acquired operations by improving clinical outcomes, quality of care, and operational results.
• Pursue a disciplined acquisition strategy to expand the company's footprint in existing and new geographic markets within the fragmented home health, hospice, and senior living industries.
• Leverage operational capabilities and data analytics to expand formal and informal partnerships across the healthcare continuum, including potential additional joint ventures.
• Monitor and adapt to the changing regulatory environment, including new CMS payment rules and the impacts of the OBBBA on Medicaid programs.
• Perform an assessment of the effectiveness of the acquired UnitedHealth and Amedisys operations' internal control over financial reporting by December 31, 2026.

Key Dates

Recommendation

The Pennant Group, Inc. demonstrates exceptional financial performance with substantial year-over-year growth in revenue, net income, and Adjusted EBITDA, significantly outpacing industry averages. Its strategic acquisition model, coupled with strong organic growth and a commitment to high-quality patient care (evidenced by superior CMS star ratings), positions it favorably in a growing healthcare market. While regulatory changes and labor costs present challenges, the company's proven ability to adapt and expand, along with a diversified service and payor mix, suggests continued strong performance and potential for long-term value creation for investors.

Keywords

Home Health, Hospice, Senior Living, Healthcare Services, Acquisitions, Organic Growth, Medicare, Medicaid, SEC Filing, 10-K, Financial Performance, PNTG, Value-Based Care, Post-Acute Care, Cybersecurity, Regulatory Compliance